{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:05:20Z","timestamp":1790791520784,"version":"4.1.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,21]]},"DOI":"10.7759\/cureus.56635","type":"journal-article","created":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T14:00:52Z","timestamp":1711029652000},"source":"Crossref","is-referenced-by-count":12,"title":["Emerging Trends in Atherosclerosis: Time to Address Atherosclerosis From a Younger Age"],"prefix":"10.7759","author":[{"given":"Yazan","family":"Almohtasib","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J","family":"Fancher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Sawalha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-021-00647-9","article-title":"Prevention of atherosclerosis from childhood","volume":"19","author":"Raitakari O","year":"2022","unstructured":"Raitakari O, Pahkala K, Magnussen CG. Prevention of atherosclerosis from childhood. Nat Rev Cardiol. 2022, 19:543-54. 10.1038\/s41569-021-00647-9","journal-title":"Nat Rev Cardiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(93)90050-B","article-title":"Manifestations of coronary atherosclerosis in young trauma victims--an autopsy study","volume":"22","author":"Joseph A","year":"1993","unstructured":"Joseph A, Ackerman D, Talley JD, Johnstone J, Kupersmith J. Manifestations of coronary atherosclerosis in young trauma victims--an autopsy study. J Am Coll Cardiol. 1993, 22:459-67. 10.1016\/0735-1097(93)90050-B","journal-title":"J Am Coll Cardiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1953.03690120006002","article-title":"Coronary disease among United States soldiers killed in action in Korea; preliminary report","volume":"152","author":"Enos WF","year":"1953","unstructured":"Enos WF, Holmes RH, Beyer J. Coronary disease among United States soldiers killed in action in Korea; preliminary report. J Am Med Assoc. 1953, 152:1090-3. 10.1001\/jama.1953.03690120006002","journal-title":"J Am Med Assoc"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199806043382302","article-title":"Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study","volume":"338","author":"Berenson GS","year":"1998","unstructured":"Berenson GS, Srinivasan SR, Bao W, Newman WP 3rd, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med. 1998, 338:1650-6. 10.1056\/NEJM199806043382302","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2010.10.040","article-title":"Increase in sudden death from coronary artery disease in young adults","volume":"161","author":"Arzamendi D","year":"2011","unstructured":"Arzamendi D, Benito B, Tizon-Marcos H, et al.. Increase in sudden death from coronary artery disease in young adults. Am Heart J. 2011, 161:574-80. 10.1016\/j.ahj.2010.10.040","journal-title":"Am Heart J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-012-0226-3","article-title":"Coronary heart disease in young adults","volume":"14","author":"Rubin JB","year":"2012","unstructured":"Rubin JB, Borden WB. Coronary heart disease in young adults. Curr Atheroscler Rep. 2012, 14:140-9. 10.1007\/s11883-012-0226-3","journal-title":"Curr Atheroscler Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/ehjci\/jeu281","article-title":"Gender differences in the prevalence, severity, and composition of coronary artery disease in the young: a study of 1635 individuals undergoing coronary CT angiography from the prospective, multinational confirm registry","volume":"16","author":"Otaki Y","year":"2015","unstructured":"Otaki Y, Gransar H, Cheng VY, et al.. Gender differences in the prevalence, severity, and composition of coronary artery disease in the young: a study of 1635 individuals undergoing coronary CT angiography from the prospective, multinational confirm registry. Eur Heart J Cardiovasc Imaging. 2015, 16:490-9. 10.1093\/ehjci\/jeu281","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4103\/HEARTVIEWS.HEARTVIEWS_49_17","article-title":"Escalation of coronary atherosclerosis in younger people by comparison of two autopsy studies conducted a decade apart","volume":"19","author":"Venkatesh K","year":"2018","unstructured":"Venkatesh K, Deepak DC, Venkatesha VT. Escalation of coronary atherosclerosis in younger people by comparison of two autopsy studies conducted a decade apart. Heart Views. 2018, 19:128-36. 10.4103\/HEARTVIEWS.HEARTVIEWS_49_17","journal-title":"Heart Views"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2019.10.020","article-title":"Risk factors and outcomes of very young adults who experience myocardial infarction: the partners young-mi Registry","volume":"133","author":"Yang J","year":"2020","unstructured":"Yang J, Biery DW, Singh A, et al.. Risk factors and outcomes of very young adults who experience myocardial infarction: the partners young-mi Registry. Am J Med. 2020, 133:605-12.e1. 10.1016\/j.amjmed.2019.10.020","journal-title":"Am J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.707529","article-title":"Role of lipid accumulation and inflammation in atherosclerosis: focus on molecular and cellular mechanisms","volume":"8","author":"Malekmohammad K","year":"2021","unstructured":"Malekmohammad K, Bezsonov EE, Rafieian-Kopaei M. Role of lipid accumulation and inflammation in atherosclerosis: focus on molecular and cellular mechanisms. Front Cardiovasc Med. 2021, 8:707529. 10.3389\/fcvm.2021.707529","journal-title":"Front Cardiovasc Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.14336\/AD.2021.0929","article-title":"The functional role of lipoproteins in atherosclerosis: novel directions for diagnosis and targeting therapy","volume":"13","author":"Lu Y","year":"2022","unstructured":"Lu Y, Cui X, Zhang L, et al.. The functional role of lipoproteins in atherosclerosis: novel directions for diagnosis and targeting therapy. Aging Dis. 2022, 13:491-520. 10.14336\/AD.2021.0929","journal-title":"Aging Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis--an inflammatory disease","volume":"340","author":"Ross R","year":"1999","unstructured":"Ross R. Atherosclerosis--an inflammatory disease. N Engl J Med. 1999, 340:115-26. 10.1056\/NEJM199901143400207","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.845942","article-title":"Foam cells in atherosclerosis: novel insights into its origins, consequences, and molecular mechanisms","volume":"9","author":"Gui Y","year":"2022","unstructured":"Gui Y, Zheng H, Cao RY. Foam cells in atherosclerosis: novel insights into its origins, consequences, and molecular mechanisms. Front Cardiovasc Med. 2022, 9:845942. 10.3389\/fcvm.2022.845942","journal-title":"Front Cardiovasc Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/biom9080301","article-title":"Antioxidants and atherosclerosis: mechanistic aspects","volume":"9","author":"Malekmohammad K","year":"2019","unstructured":"Malekmohammad K, Sewell RD, Rafieian-Kopaei M. Antioxidants and atherosclerosis: mechanistic aspects. Biomolecules. 2019, 9:301. 10.3390\/biom9080301","journal-title":"Biomolecules"},{"key":"ref15","article-title":"Obesity and obesity-induced inflammatory disease contribute to atherosclerosis: a review of the pathophysiology and treatment of obesity","volume":"11","author":"Henning RJ","year":"2021","unstructured":"Henning RJ. Obesity and obesity-induced inflammatory disease contribute to atherosclerosis: a review of the pathophysiology and treatment of obesity. Am J Cardiovasc Dis. 2021, 11:504-29.","journal-title":"Am J Cardiovasc Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/nu5041218","article-title":"Dyslipidemia in obesity: mechanisms and potential targets","volume":"5","author":"Klop B","year":"2013","unstructured":"Klop B, Elte JW, Cabezas MC. Dyslipidemia in obesity: mechanisms and potential targets. Nutrients. 2013, 5:1218-40. 10.3390\/nu5041218","journal-title":"Nutrients"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.571731","article-title":"Gut microbiota as a trigger for metabolic inflammation in obesity and type 2 diabetes","volume":"11","author":"Scheithauer TP","year":"2020","unstructured":"Scheithauer TP, Rampanelli E, Nieuwdorp M, Vallance BA, Verchere CB, van Raalte DH, Herrema H. Gut microbiota as a trigger for metabolic inflammation in obesity and type 2 diabetes. Front Immunol. 2020, 11:571731. 10.3389\/fimmu.2020.571731","journal-title":"Front Immunol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.119.315896","article-title":"Metabolic inflammation and insulin resistance in obesity","volume":"126","author":"Wu H","year":"2020","unstructured":"Wu H, Ballantyne CM. Metabolic inflammation and insulin resistance in obesity. Circ Res. 2020, 126:1549-64. 10.1161\/CIRCRESAHA.119.315896","journal-title":"Circ Res"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/s0828-282x(06)70314-2","article-title":"Reactive oxygen species and vascular remodelling in hypertension: still alive","volume":"22","author":"Xu S","year":"2006","unstructured":"Xu S, Touyz RM. Reactive oxygen species and vascular remodelling in hypertension: still alive. Can J Cardiol. 2006, 22:947-51. 10.1016\/s0828-282x(06)70314-2","journal-title":"Can J Cardiol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(76)90357-X","article-title":"Role of hypertension in atherosclerosis and cardiovascular disease","volume":"38","author":"Hollander W","year":"1976","unstructured":"Hollander W. Role of hypertension in atherosclerosis and cardiovascular disease. Am J Cardiol. 1976, 38:786-800. 10.1016\/0002-9149(76)90357-X","journal-title":"Am J Cardiol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.2307","article-title":"Cardiovascular risk factor prevalence, treatment, and control in US adults aged 20 to 44 years, 2009 to March 2020","volume":"329","author":"Aggarwal R","year":"2023","unstructured":"Aggarwal R, Yeh RW, Joynt Maddox KE, Wadhera RK. Cardiovascular risk factor prevalence, treatment, and control in US adults aged 20 to 44 years, 2009 to March 2020. JAMA. 2023, 329:899-909. 10.1001\/jama.2023.2307","journal-title":"JAMA"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.47484","article-title":"Our hidden enemy: Ultra-processed foods, inflammation, and the battle for heart health","volume":"15","author":"Sawalha K","year":"2023","unstructured":"Sawalha K, Tripathi V, Alkhatib D, Alalawi L, Mahmood A, Alexander T. Our hidden enemy: Ultra-processed foods, inflammation, and the battle for heart health. Cureus. 2023, 15:e47484. 10.7759\/cureus.47484","journal-title":"Cureus"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-009892","article-title":"Ultra-processed foods and added sugars in the US diet: evidence from a nationally representative cross-sectional study","volume":"6","author":"Mart\u00ednez Steele E","year":"2016","unstructured":"Mart\u00ednez Steele E, Baraldi LG, Louzada ML, Moubarac JC, Mozaffarian D, Monteiro CA. Ultra-processed foods and added sugars in the US diet: evidence from a nationally representative cross-sectional study. BMJ Open. 2016, 6:e009892. 10.1136\/bmjopen-2015-009892","journal-title":"BMJ Open"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1590\/S0034-8910.2015049006132","article-title":"Ultra-processed foods and the nutritional dietary profile in Brazil","volume":"49","author":"Costa Louzada ML","year":"2015","unstructured":"Costa Louzada ML, Martins AP, Canella DS, et al.. Ultra-processed foods and the nutritional dietary profile in Brazil. Rev Saude Publica. 2015, 49:38. 10.1590\/S0034-8910.2015049006132","journal-title":"Rev Saude Publica"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1590\/s0102-311x2010001100005","article-title":"A new classification of foods based on the extent and purpose of their processing","volume":"26","author":"Monteiro CA","year":"2010","unstructured":"Monteiro CA, Levy RB, Claro RM, Castro IR, Cannon G. A new classification of foods based on the extent and purpose of their processing. Cad Saude Publica. 2010, 26:2039-49. 10.1590\/s0102-311x2010001100005","journal-title":"Cad Saude Publica"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1017\/S0007114518001046","article-title":"Ultra-processed food consumption and excess weight among US adults","volume":"120","author":"Juul F","year":"2018","unstructured":"Juul F, Martinez-Steele E, Parekh N, Monteiro CA, Chang VW. Ultra-processed food consumption and excess weight among US adults. Br J Nutr. 2018, 120:90-100. 10.1017\/S0007114518001046","journal-title":"Br J Nutr"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1038\/s41430-022-01099-1","article-title":"Ultra-processed foods: how functional is the NOVA system?","volume":"76","author":"Braesco V","year":"2022","unstructured":"Braesco V, Souchon I, Sauvant P, Haurogn\u00e9 T, Maillot M, F\u00e9art C, Darmon N. Ultra-processed foods: how functional is the NOVA system?. Eur J Clin Nutr. 2022, 76:1245-53. 10.1038\/s41430-022-01099-1","journal-title":"Eur J Clin Nutr"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1038\/s41366-020-00650-z","article-title":"Ultra-processed food and the risk of overweight and obesity: a systematic review and meta-analysis of observational studies","volume":"44","author":"Askari M","year":"2020","unstructured":"Askari M, Heshmati J, Shahinfar H, Tripathi N, Daneshzad E. Ultra-processed food and the risk of overweight and obesity: a systematic review and meta-analysis of observational studies. Int J Obes (Lond). 2020, 44:2080-91. 10.1038\/s41366-020-00650-z","journal-title":"Int J Obes (Lond)"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.hjc.2023.07.010","article-title":"Association between ultra-processed foods consumption and the risk of hypertension: an umbrella review of systematic reviews","volume":"76","author":"Wang Z","year":"2024","unstructured":"Wang Z, Lu C, Wang Y, E F, Mentis AF, Li X, Yang K. Association between ultra-processed foods consumption and the risk of hypertension: an umbrella review of systematic reviews. Hellenic J Cardiol. 2024, 76:99-109. 10.1016\/j.hjc.2023.07.010","journal-title":"Hellenic J Cardiol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3390\/nu13124410","article-title":"Ultra-processed food consumption and adult diabetes risk: a systematic review and dose-response meta-analysis","volume":"13","author":"Moradi S","year":"2021","unstructured":"Moradi S, Hojjati Kermani MA, Bagheri R, et al.. Ultra-processed food consumption and adult diabetes risk: a systematic review and dose-response meta-analysis. Nutrients. 2021, 13:10.3390\/nu13124410","journal-title":"Nutrients"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.advnut.2023.09.009","article-title":"Ultra-processed foods and human health: a systematic review and meta-analysis of prospective cohort studies","volume":"15","author":"Vitale M","year":"2024","unstructured":"Vitale M, Costabile G, Testa R, D'Abbronzo G, Nettore IC, Macchia PE, Giacco R. Ultra-processed foods and human health: a systematic review and meta-analysis of prospective cohort studies. Adv Nutr. 2024, 15:100121. 10.1016\/j.advnut.2023.09.009","journal-title":"Adv Nutr"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/nxab285","article-title":"Higher ultra-processed food consumption is associated with increased risk of incident coronary artery disease in the Atherosclerosis Risk in Communities study","volume":"151","author":"Du S","year":"2021","unstructured":"Du S, Kim H, Rebholz CM. Higher ultra-processed food consumption is associated with increased risk of incident coronary artery disease in the Atherosclerosis Risk in Communities study. J Nutr. 2021, 151:3746-54. 10.1093\/jn\/nxab285","journal-title":"J Nutr"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1161\/hc0902.104353","article-title":"Inflammation and atherosclerosis","volume":"105","author":"Libby P","year":"2002","unstructured":"Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002, 105:1135-43. 10.1161\/hc0902.104353","journal-title":"Circulation"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1042\/CS20180306","article-title":"Atherosclerosis and inflammation: overview and updates","volume":"132","author":"Geovanini GR","year":"2018","unstructured":"Geovanini GR, Libby P. Atherosclerosis and inflammation: overview and updates. Clin Sci (Lond). 2018, 132:1243-52. 10.1042\/CS20180306","journal-title":"Clin Sci (Lond)"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.39395","article-title":"Epigenetic regulation and its effects on aging and cardiovascular disease","volume":"15","author":"Sawalha K","year":"2023","unstructured":"Sawalha K, Norgard N, L\u00f3pez-Candales A. Epigenetic regulation and its effects on aging and cardiovascular disease. Cureus. 2023, 15:e39395. 10.7759\/cureus.39395","journal-title":"Cureus"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.2217\/epi.13.83","article-title":"Epigenetics: where environment, society and genetics meet","volume":"6","author":"Majnik AV","year":"2014","unstructured":"Majnik AV, Lane RH. Epigenetics: where environment, society and genetics meet. Epigenomics. 2014, 6:1-4. 10.2217\/epi.13.83","journal-title":"Epigenomics"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.985274","article-title":"The epigenetic aging, obesity, and lifestyle","volume":"10","author":"Franzago M","year":"2022","unstructured":"Franzago M, Pilenzi L, Di Rado S, Vitacolonna E, Stuppia L. The epigenetic aging, obesity, and lifestyle. Front Cell Dev Biol. 2022, 10:985274. 10.3389\/fcell.2022.985274","journal-title":"Front Cell Dev Biol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1186\/s12881-015-0174-1","article-title":"Leptin and adiponectin DNA methylation levels in adipose tissues and blood cells are associated with BMI, waist girth and LDL-cholesterol levels in severely obese men and women","volume":"16","author":"Houde AA","year":"2015","unstructured":"Houde AA, L\u00e9gar\u00e9 C, Biron S, et al.. Leptin and adiponectin DNA methylation levels in adipose tissues and blood cells are associated with BMI, waist girth and LDL-cholesterol levels in severely obese men and women. BMC Med Genet. 2015, 16:29. 10.1186\/s12881-015-0174-1","journal-title":"BMC Med Genet"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1080\/15592294.2019.1595297","article-title":"DNA methylation markers in obesity, metabolic syndrome, and weight loss","volume":"14","author":"Samblas M","year":"2019","unstructured":"Samblas M, Milagro FI, Mart\u00ednez A. DNA methylation markers in obesity, metabolic syndrome, and weight loss. Epigenetics. 2019, 14:421-44. 10.1080\/15592294.2019.1595297","journal-title":"Epigenetics"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8585","article-title":"Obesity-induced DNA hypermethylation of the adiponectin gene mediates insulin resistance","volume":"6","author":"Kim AY","year":"2015","unstructured":"Kim AY, Park YJ, Pan X, et al.. Obesity-induced DNA hypermethylation of the adiponectin gene mediates insulin resistance. Nat Commun. 2015, 6:7585. 10.1038\/ncomms8585","journal-title":"Nat Commun"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M208511200","article-title":"Leptin gene expression in human preadipocytes is switched on by maturation-induced demethylation of distinct CpGs in its proximal promoter","volume":"277","author":"Melzner I","year":"2002","unstructured":"Melzner I, Scott V, Dorsch K, et al.. Leptin gene expression in human preadipocytes is switched on by maturation-induced demethylation of distinct CpGs in its proximal promoter. J Biol Chem. 2002, 277:45420-7. 10.1074\/jbc.M208511200","journal-title":"J Biol Chem"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2016.08.010","article-title":"AMPK\/\u03b1-ketoglutarate axis dynamically mediates DNA demethylation in the Prdm16 promoter and brown adipogenesis","volume":"24","author":"Yang Q","year":"2016","unstructured":"Yang Q, Liang X, Sun X, et al.. AMPK\/\u03b1-ketoglutarate axis dynamically mediates DNA demethylation in the Prdm16 promoter and brown adipogenesis. Cell Metab. 2016, 24:542-54. 10.1016\/j.cmet.2016.08.010","journal-title":"Cell Metab"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2006.10.004","article-title":"Epigenetic changes in estrogen receptor beta gene in atherosclerotic cardiovascular tissues and in-vitro vascular senescence","volume":"1772","author":"Kim J","year":"2007","unstructured":"Kim J, Kim JY, Song KS, et al.. Epigenetic changes in estrogen receptor beta gene in atherosclerotic cardiovascular tissues and in-vitro vascular senescence. Biochim Biophys Acta. 2007, 1772:72-80. 10.1016\/j.bbadis.2006.10.004","journal-title":"Biochim Biophys Acta"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(99)00153-4","article-title":"Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system","volume":"43","author":"Post WS","year":"1999","unstructured":"Post WS, Goldschmidt-Clermont PJ, Wilhide CC, et al.. Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system. Cardiovasc Res. 1999, 43:985-991. 10.1016\/S0008-6363(99)00153-4","journal-title":"Cardiovasc Res"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2011-100195","article-title":"Promoter methylation in coagulation F7 gene influences plasma FVII concentrations and relates to coronary artery disease","volume":"49","author":"Friso S","year":"2012","unstructured":"Friso S, Lotto V, Choi SW, et al.. Promoter methylation in coagulation F7 gene influences plasma FVII concentrations and relates to coronary artery disease. J Med Genet. 2012, 49:192-9. 10.1136\/jmedgenet-2011-100195","journal-title":"J Med Genet"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1177\/2040622314529325","article-title":"The emerging role of epigenetics in cardiovascular disease","volume":"5","author":"Khalil CA","year":"2014","unstructured":"Khalil CA. The emerging role of epigenetics in cardiovascular disease. Ther Adv Chronic Dis. 2014, 5:178-87. 10.1177\/2040622314529325","journal-title":"Ther Adv Chronic Dis"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1101\/gr.116095.110","article-title":"Genome-wide analysis distinguishes hyperglycemia regulated epigenetic signatures of primary vascular cells","volume":"21","author":"Pirola L","year":"2011","unstructured":"Pirola L, Balcerczyk A, Tothill RW, et al.. Genome-wide analysis distinguishes hyperglycemia regulated epigenetic signatures of primary vascular cells. Genome Res. 2011, 21:1601-15. 10.1101\/gr.116095.110","journal-title":"Genome Res"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1097\/MOL.0b013e32834f319d","article-title":"Glycemic memory","volume":"23","author":"El-Osta A","year":"2012","unstructured":"El-Osta A. Glycemic memory. Curr Opin Lipidol. 2012, 23:24-9. 10.1097\/MOL.0b013e32834f319d","journal-title":"Curr Opin Lipidol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-014-0476-3","article-title":"Epigenetic reprogramming in atherosclerosis","volume":"17","author":"Grimaldi V","year":"2015","unstructured":"Grimaldi V, Vietri MT, Schiano C, et al.. Epigenetic reprogramming in atherosclerosis. Curr Atheroscler Rep. 2015, 17:476. 10.1007\/s11883-014-0476-3","journal-title":"Curr Atheroscler Rep"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1017\/S0007114520001981","article-title":"Higher ultra-processed food intake is associated with higher DNA damage in healthy adolescents","volume":"125","author":"Edalati S","year":"2021","unstructured":"Edalati S, Bagherzadeh F, Jafarabadi MA, Ebrahimi-Mamaghani M. Higher ultra-processed food intake is associated with higher DNA damage in healthy adolescents. Br J Nutr. 2021, 125:568-76. 10.1017\/S0007114520001981","journal-title":"Br J Nutr"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1093\/eurjpc\/zwac309","article-title":"High-intensity interval training induces beneficial effects on coronary atheromatous plaques: a randomized trial","volume":"30","author":"Vesterbekkmo EK","year":"2023","unstructured":"Vesterbekkmo EK, Akset\u00f8y IA, Follestad T, et al.. High-intensity interval training induces beneficial effects on coronary atheromatous plaques: a randomized trial. Eur J Prev Cardiol. 2023, 30:384-92. 10.1093\/eurjpc\/zwac309","journal-title":"Eur J Prev Cardiol"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2020.10.019","article-title":"High-risk coronary plaque regression after intensive lifestyle intervention in nonobstructive coronary disease: a randomized study","volume":"14","author":"Henzel J","year":"2021","unstructured":"Henzel J, K\u0119pka C, Kruk M, et al.. High-risk coronary plaque regression after intensive lifestyle intervention in nonobstructive coronary disease: a randomized study. JACC Cardiovasc Imaging. 2021, 14:1192-202. 10.1016\/j.jcmg.2020.10.019","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.9.1071","article-title":"Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial","volume":"291","author":"Nissen SE","year":"2004","unstructured":"Nissen SE, Tuzcu EM, Schoenhagen P, et al.. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA. 2004, 291:1071-80. 10.1001\/jama.291.9.1071","journal-title":"JAMA"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.2217\/14796678.2.6.651","article-title":"The ASTEROID trial: coronary plaque regression with high-dose statin therapy","volume":"2","author":"Chhatriwalla AK","year":"2006","unstructured":"Chhatriwalla AK, Nicholls SJ, Nissen SE. The ASTEROID trial: coronary plaque regression with high-dose statin therapy. Future Cardiol. 2006, 2:651-4. 10.2217\/14796678.2.6.651","journal-title":"Future Cardiol"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1110874","article-title":"Effect of two intensive statin regimens on progression of coronary disease","volume":"365","author":"Nicholls SJ","year":"2011","unstructured":"Nicholls SJ, Ballantyne CM, Barter PJ, et al.. Effect of two intensive statin regimens on progression of coronary disease. N Engl J Med. 2011, 365:2078-87. 10.1056\/NEJMoa1110874","journal-title":"N Engl J Med"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-87528-w","article-title":"The effects of lipid-lowering therapy on coronary plaque regression: a systematic review and meta-analysis","volume":"11","author":"Li Y","year":"2021","unstructured":"Li Y, Deng S, Liu B, et al.. The effects of lipid-lowering therapy on coronary plaque regression: a systematic review and meta-analysis. Sci Rep. 2021, 11:7999. 10.1038\/s41598-021-87528-w","journal-title":"Sci Rep"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.019014\/FORMAT\/EPUB","article-title":"Long-term safety and efficacy of lowering low-density lipoprotein cholesterol with statin therapy 20-year follow-up of west of Scotland coronary prevention study","volume":"133","author":"Ford I","year":"2016","unstructured":"Ford I, Murray H, McCowan C, Packard CJ. Long-term safety and efficacy of lowering low-density lipoprotein cholesterol with statin therapy 20-year follow-up of west of Scotland coronary prevention study. Circulation. 2016, 133:1073-80. 10.1161\/CIRCULATIONAHA.115.019014\/FORMAT\/EPUB","journal-title":"Circulation"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.10.035","article-title":"Coronary atherosclerotic plaque regression: JACC state-of-the-art review","volume":"79","author":"Dawson LP","year":"2022","unstructured":"Dawson LP, Lum M, Nerleker N, Nicholls SJ, Layland J. Coronary atherosclerotic plaque regression: JACC state-of-the-art review. J Am Coll Cardiol. 2022, 79:66-82. 10.1016\/j.jacc.2021.10.035","journal-title":"J Am Coll Cardiol"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000437741.48606.98","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Goff DC Jr","year":"2014","unstructured":"Goff DC Jr, Lloyd-Jones DM, Bennett G, et al.. 2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. Circulation. 2014, 129:S49-73. 10.1161\/01.cir.0000437741.48606.98","journal-title":"Circulation"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1093\/OXFORDJOURNALS.AJE.A115184","article-title":"The Atherosclerosis Risk in communit (ARIC) study: design and objectives","volume":"129","author":"The ARIC investigators","year":"1989","unstructured":"The ARIC investigators. The Atherosclerosis Risk in communit (ARIC) study: design and objectives. Am J Epidemiol. 1989, 129:687-702. 10.1093\/OXFORDJOURNALS.AJE.A115184","journal-title":"Am J Epidemiol"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(88)90080-7","article-title":"CARDIA: study design, recruitment, and some characteristics of the examined subjects","volume":"41","author":"Friedman GD","year":"1988","unstructured":"Friedman GD, Cutter GR, Donahue RP, et al.. CARDIA: study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol. 1988, 41:1105-16. 10.1016\/0895-4356(88)90080-7","journal-title":"J Clin Epidemiol"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1963.tb13299.x","article-title":"An approach to longitudinal studies in a community: the Framingham Study","volume":"107","author":"Dawber TR","year":"1963","unstructured":"Dawber TR, Kannel WB, Lyell LP. An approach to longitudinal studies in a community: the Framingham Study. Ann N Y Acad Sci. 1963, 107:539-56. 10.1111\/j.1749-6632.1963.tb13299.x","journal-title":"Ann N Y Acad Sci"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2261-14-163","article-title":"Validation of the pooled cohort risk score in an Asian population - a retrospective cohort study","volume":"14","author":"Chia YC","year":"2014","unstructured":"Chia YC, Lim HM, Ching SM. Validation of the pooled cohort risk score in an Asian population - a retrospective cohort study. BMC Cardiovasc Disord. 2014, 14:163. 10.1186\/1471-2261-14-163","journal-title":"BMC Cardiovasc Disord"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.11.002","article-title":"2018 AHA\/ACC\/Aacvpr\/AAPA\/ABC\/ACPM\/Ada\/AGS\/APHA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines","volume":"73","author":"Grundy SM","year":"2019","unstructured":"Grundy SM, Stone NJ, Bailey AL, et al.. 2018 AHA\/ACC\/Aacvpr\/AAPA\/ABC\/ACPM\/Ada\/AGS\/APHA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines. J Am Coll Cardiol. 2019, 73:3168-209. 10.1016\/j.jacc.2018.11.002","journal-title":"J Am Coll Cardiol"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.13044","article-title":"Statin use for the primary prevention of cardiovascular disease in adults: US Preventive Services Task Force recommendation statement","volume":"328","author":"Mangione CM","year":"2022","unstructured":"Mangione CM, Barry MJ, Nicholson WK, et al.. Statin use for the primary prevention of cardiovascular disease in adults: US Preventive Services Task Force recommendation statement. JAMA. 2022, 328:746-53. 10.1001\/jama.2022.13044","journal-title":"JAMA"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2023.09.814","article-title":"Determinants of progression and regression of subclinical atherosclerosis over 6 years","volume":"82","author":"Mendieta G","year":"2023","unstructured":"Mendieta G, Pocock S, Mass V, et al.. Determinants of progression and regression of subclinical atherosclerosis over 6 years. J Am Coll Cardiol. 2023, 82:2069-83. 10.1016\/j.jacc.2023.09.814","journal-title":"J Am Coll Cardiol"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.966465","article-title":"Influence of age on associations between childhood risk factors and carotid intima-media thickness in adulthood: the cardiovascular risk in Young Finns study, the childhood determinants of adult health study, the Bogalusa Heart Study, and the Muscatine Study for the International Childhood Cardiovascular Cohort (i3C) Consortium","volume":"122","author":"Juonala M","year":"2010","unstructured":"Juonala M, Magnussen CG, Venn A, et al.. Influence of age on associations between childhood risk factors and carotid intima-media thickness in adulthood: the cardiovascular risk in Young Finns study, the childhood determinants of adult health study, the Bogalusa Heart Study, and the Muscatine Study for the International Childhood Cardiovascular Cohort (i3C) Consortium. Circulation. 2010, 122:2514-20. 10.1161\/CIRCULATIONAHA.110.966465","journal-title":"Circulation"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.07.059","article-title":"Time course of LDL cholesterol exposure and cardiovascular disease event risk","volume":"76","author":"Domanski MJ","year":"2020","unstructured":"Domanski MJ, Tian X, Wu CO, et al.. Time course of LDL cholesterol exposure and cardiovascular disease event risk. J Am Coll Cardiol. 2020, 76:1507-16. 10.1016\/j.jacc.2020.07.059","journal-title":"J Am Coll Cardiol"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1816454","article-title":"20-year follow-up of statins in children with familial hypercholesterolemia","volume":"381","author":"Luirink IK","year":"2019","unstructured":"Luirink IK, Wiegman A, Kusters DM, et al.. 20-year follow-up of statins in children with familial hypercholesterolemia. N Engl J Med. 2019, 381:1547-56. 10.1056\/NEJMoa1816454","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/239115-emerging-trends-in-atherosclerosis-time-to-address-atherosclerosis-from-a-younger-age","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T14:00:56Z","timestamp":1711029656000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/239115-emerging-trends-in-atherosclerosis-time-to-address-atherosclerosis-from-a-younger-age"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,21]]},"references-count":69,"URL":"https:\/\/doi.org\/10.7759\/cureus.56635","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3,21]]}}}